Synthesis and determination of the absolute configuration of the enantiomers of modafinil

Tetrahedron Asymmetry

Volumn 15, Issue 6, 2004, Pages 1053-1058

  Prisinzano, Thomas ^a   Podobinski, John ^a   Tidgewell, Kevin ^a   Luo, Min ^a   Swenson, Dale ^b  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(DIPHENYLMETHANESULFINYL)ACETIC ACID; ACETIC ACID; ADRAFINIL; BENZENE; BENZHYDROL; CENTRAL STIMULANT AGENT; METHANE; MODAFINIL; PHENYL GROUP; SULFINIC ACID DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ANALYTIC METHOD; ARTICLE; ASYMMETRIC SYNTHESIS; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; ENANTIOMER; ISOMER; PRIORITY JOURNAL; REDUCTION KINETICS; STRUCTURE ANALYSIS; X RAY ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 1542606238     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetasy.2004.01.039     Document Type: Article

References (37)

1. Becker P.M., Schwartz J.R., Feldman N.T., Hughes R.J. Psychopharmacology. 171:2004;133-139.
2. Nishino S., Mignot E. Prog. Neurobiol. 52:1997;27-78.
3. Scammell T.E. Ann. Neurol. 53:2003;154-166.
4. Pliszka S.R. CNS Spectrosc. 8:2003;253-258.
5. Spencer T., Biederman J. J. Atten. Disord. 6(Suppl 1):2002;S109-S119.
6. Teitelman E. Am. J. Psychiatry. 158:2001;970-971.
7. Webster L., Andrews M., Stoddard G. Pain Med. 4:2003;135-140.
8. Gold L.H., Balster R.L. Psychopharmacology. 126:1996;286-292.
9. Teitelman E. Am. J. Psychiatry. 158:2001;1341.
10. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F.A., Fuxe K. Biol. Psychiatry. 42:1997;1181-1183.
11. Ferraro L., Antonelli T., Tanganelli S., O'Connor W.T., Perez de la Mora M., Mendez-Franco J., Rambert F.A., Fuxe K. Neuropsychopharmacology. 20:1999;346-356.
12. Malcolm R., Book S.W., Moak D., DeVane L., Czepowicz V. Am. J. Addict. 11:2002;247-249.
13. Dackis C.A., Lynch K.G., Yu E., Samaha F.F., Kampman K.M., Cornish J.W., Rowan A., Poole S., White L., O'Brien C.P. Drug Alcohol Depend. 70:2003;29-37.
14. Camacho A., Stein M.B. Am. J. Psychiatry. 159:2002;1947-1948.
15. Mignot E., Nishino S., Guilleminault C., Dement W.C. Sleep. 17:1994;436-437.
16. Ferraro L., Tanganelli S., O'Connor W.T., Antonelli T., Rambert F., Fuxe K. Eur. J. Pharmacol. 306:1996;33-39.
17. Ferraro L., Fuxe K., Tanganelli S., Fernandez M., Rambert F.A., Antonelli T. Neuropharmacology. 39:2000;1974-1983.
18. Donovan J.L., Malcolm R.J., Markowitz J.S., DeVane C.L. Ther. Drug Monit. 25:2003;197-202.
19. Wong Y.N., King S.P., Simcoe D., Gorman S., Laughton W., McCormick G.C., Grebow P. J. Clin. Pharmacol. 39:1999;281-288.
20. Carceller E., Merlos M., Giral M., Almansa C., Bartroli J., Garcia-Rafanell J., Forn J. J. Med. Chem. 36:1993;2984-2997.
21. Brannigan, L. H.; Brinker, R. J.; Kaufman, R. J.; Metz, S. U.S. Patent 4,964,893, 1990.
22. Lafon, L. U.S. Patent 4,177,290, 1978.
23. Lafon, L. U.S. Patent 4,066,686, 1978.
24. Zhao S.H., Samuel O., Kagan H.B. Tetrahedron. 43:1987;5135-5144.
25. Pitchen P., France C.J., McFarlane I.M., Newton C.G., Thompson D.M. Tetrahedron Lett. 35:1994;485-488.
26. Madesclaire M. Tetrahedron. 42:1986;5459-5495.
27. Kagan H.B., Rebiere F., Samuel O. Phosphorus Sulfur. 58:1991;89-110.
28. Davis R., Kern J.R., Kurz L.J., Pfister J.R. J. Am. Chem. Soc. 110:1988;7873-7874.
29. Lafon, L. U.S. Patent 4,927,855, 1990.
30. Leonard N.J., Johnson C.R. J. Org. Chem. 27:1962;282-284.
31. Shukla V.G., Salgaonkar P.D., Akamanchi K.G. J. Org. Chem. 68:2003;5422-5424.
32. Drabowicz J., Lyzwa P., Popielarczyk M., Mikolajczyk M. Synthesis. 1990;937-938.
33. Prisinzano T., Hsin L.W., Folk J.E., Flippen-Anderson J.L., George C., Jacobson A.E., Rice K.C. Tetrahedron: Asymmetry. 14:2003;3285-3289.
34. Nonius (1997-2000) COLLECT; Nonius BV, Delft, The Netherlands.
35. Otwinowski, Z.; Minor, W. Scalepack; International Tables for Crystallography, Vol. F, 2001.
36. Sheldrick, G.M. SHELXTL Version 6.1; Bruker Analytical X-ray Instruments: Madison, WI, 1997.
37. Flack H.D. Acta Cryst. A. 46:1990;467-473.